![]() |
|
|
Department of Food Science and Human Nutrition, Washington State University, Pullman, WA 99164-6376
3To whom correspondence should be addressed. E-mail: shultz{at}wsu.edu.
| ABSTRACT |
|---|
|
|
|---|
0.05 for both) by d 58 and 84, respectively, and EAST basal
activity decreased 40% (P
0.05) by d 58. In
-80 and -196°C samples, EALT and EAST basal activities did not
change significantly. Activity coefficients did not differ
significantly from d 0 at any storage temperature, but EAST-AC
increased 919% (nonsignificant) in samples stored at -20 and
-80°C for 7 to 84 d. Additionally, EAST-AC was
significantly higher in -20 than -80 and -196°C samples on d 1 and
58, respectively. Erythrocytes may be frozen for 28 d at -20°C
and 84 d at -80°C before analysis for EALT; for EAST, activity
should be measured on fresh erythrocytes.
KEY WORDS: erythrocyte alanine and aspartate aminotransferases storage stability basal activity activity coefficient
| INTRODUCTION |
|---|
|
|
|---|
According to recent studies in women, EALT and EAST activities (AC or
percentage of stimulation) are sensitive measurements related to
vitamin B-6 intake (1
,2)
, although EALT is considered to
be more sensitive to changes in intake (1
,5)
. Huang et al.
(2)
, however, recently reported that EAST activity
responded more readily to changes in vitamin B-6 intake than did EALT
activity. Several researchers (2
,6
,7)
have suggested that
EALT and EAST analyses be conducted the same day that blood is drawn to
prevent possible loss of activity due to freezing. However, no detailed
studies pertaining to stability are available in the literature,
despite the fact that such information is important when laboratory
determinations must be delayed or a large number of samples analyzed.
Thus, the stability of enzyme activities with frozen storage is
important to consider.
In the present study, the stability of EALT and EAST activities was assessed in erythrocytes from three individuals frozen at different temperatures for varying periods of time ranging from 1 to 84 d. In particular, the usefulness of storage in ordinary and low temperature freezers (-20 and -80°C) was investigated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Three healthy subjects (1 man, 2 women) between the ages of 24 and
52 y, who were nonsmokers and not using oral contraceptives,
participated in this study. Subjects were screened for history of
intestinal, renal or metabolic disorders that could affect absorption,
excretion or metabolism of vitamin B-6 (8)
. The study
protocol was approved by the Human Subjects Institutional Review Board
of Washington State University and informed consent was obtained from
each subject.
Sample collection and storage.
Blood samples (60 mL) were taken from fasting subjects by venipuncture at the beginning of the study. Blood specimens were collected in heparinized Vacutainer tubes (Becton Dickinson, Rutherford, NJ). Samples were centrifuged at 1700 x g for 10 min at 4°C. Plasma was separated from erythrocytes and the buffy coat discarded. Erythrocytes were washed three times with normal saline. The erythrocytes from each subject were then separately pooled in 100-mL beakers in an ice slurry, gently mixed, divided into aliquots and stored frozen at -20 and -80°C, and under liquid nitrogen (-196°C). Fresh erythrocytes representing d 0 were assayed for EALT and EAST activities. Additional enzyme activities were measured from aliquots frozen at -20 and -80°C on d 1, 7, 14, 28, 58 and 84, and for aliquots frozen at -196°C on d 28, 58 and 84.
Sample analyses.
Erythrocyte alanine and aspartate aminotransferase activities with and
without PLP stimulation in vitro were analyzed by the method of
Woodring and Storvick (7)
using 0.33 mol/L Tris buffer (pH
7.4). Hemolysates were prepared by diluting packed cells 1:5 and 1:10
with deionized water for EALT and EAST, respectively. Briefly, in both
assays, 0.1 mL hemolysate was incubated with alanine or aspartate for
60 min at 37°C, in the presence and absence of excess PLP. After the
reaction was stopped with trichloroacetic acid, 20 µL
aniline citrate was added to the EAST reaction mixture to convert
oxaloacetate to pyruvate. One milliliter of 1 g/L
dinitrophenylhydrazine in 2.4 mol/L HCl, which reacts with pyruvate,
was added and then extracted from the reaction mixture with 1 mL
toluene. Pyruvate-dinitrophenylhydrazine formed a colored compound
when 1 mL alcoholic potassium hydroxide (25 g NaOH/L ethanol) was
added. The absorbance, read at 490 nm, is proportional to the
concentration of product (pyruvate) formed. Hemoglobin (Hb) concentration of the packed erythrocytes was determined by a
cyanmethemoglobin method (Sigma Chemical, St. Louis, MO).
Enzyme activities were expressed as mmol pyruvate/(L packed
erythrocytes · h) or mmol pyruvate/(g Hb · h) and converted to
µkat/L RBC and µkat/g Hb. The
activity coefficient was calculated by the ratio of stimulated (PLP
added) to unstimulated activity. Erythrocyte aminotransferase activity
measurements were carried out under yellow light to prevent
photodestruction. All analyses were performed in triplicate.
Statistical analysis.
Data were analyzed using the JMP statistical analysis computer program
and SAS version 6.12 (SAS Institute, Cary, NC). Means and standard
deviations were calculated at each time point for all measurements.
Repeated-measures ANOVA was used to test for statistical
differences among means. Dunnetts test was used to compare EALT and
EAST mean basal activities and activity coefficients at each time point
with d 0. The least significant difference (LSD) multiple comparison
test was used to compare means of different storage temperatures at the
same time point. Statistical comparisons were considered to be
significant at P
0.05. Values are means ± SD.
| RESULTS |
|---|
|
|
|---|
In erythrocytes frozen at -20°C, EALT basal activity was 16% lower
(P
0.07) by d 14 compared with d 0 (Fig. 1
, upper panel). There were also 17 and 22% decreases in
basal activity by d 58 and 84 (P
0.05 for both) in
the samples frozen at -20°C. In addition, EALT basal activity in
samples frozen at -20°C was 14% lower than in samples frozen at
-80°C by d 14, 20% lower by d 58 and 24% lower by d 84
(P
0.05 for all comparisons). On d 28, 58 and 84,
samples frozen at -20°C had 22, 21 and 29% lower basal activity,
respectively, than samples frozen at -196°C (P
0.05 for all comparisons). Basal activity of EALT in samples frozen at
-80°C and -196°C did not differ significantly from d 0 at any
time points. Although the EALT-AC was not significantly different
from d 0 at any time point in samples frozen at all three temperatures
(Fig. 1
, lower panel), on d 7 and 28, the activity
coefficients were 7% (P
0.05) and 5% higher
(P
0.11) in samples frozen at -20°C than in those
frozen at -80°C.
|
0.05) (Fig. 2
0.05) in samples frozen at -20°C than in
samples frozen at -196°C on d 58. Erythrocyte aspartate
aminotransferase activity coefficients were not significantly different
from d 0 at any time point in samples frozen at all three temperatures
(Fig. 2
0.05 for both).
|
| DISCUSSION |
|---|
|
|
|---|
Rose et al. (6)
also reported that EAST basal activity
decreased 2230% when hemolysates were stored for 1015 d at
-20°C. In the present study, EAST basal activity in packed cells
frozen at -20°C decreased significantly (40%) by d 58 and then
increased to greater than baseline on d 84. High intra- and interassay
variability in the EAST assay is one possible explanation for this
observation. Intra-assay variability between replicates in the EAST
procedure was > 2 times higher than in the EALT procedure,
whereas interassay variability in EAST basal activity measurements was
12 times higher than variability in EALT basal activity in samples
frozen at -20 and -80°C throughout the course of the study. Skala
et al. (11)
reported that EAST basal activity was stable
for up to 76 d at -70°C.
Nevertheless, studies evaluating vitamin B-6 status usually employ
activity coefficients rather than basal activities. Activity
coefficients of EALT did not differ from d 0 at any of the time points
or storage temperatures, although there was a downward trend after
28 d of storage. There were, however, nonsignificant increases (17
and 18%, P = 0.60 and 0.25, respectively) in EAST
activity coefficients in samples frozen at -20 and -80°C by d 7,
and EAST-AC was significantly higher (38%) in samples frozen at
-20°C compared with samples frozen at -80°C after only 1 d
of storage. The tendency for EAST basal activity to decrease while the
activity coefficient increases again implies that with frozen storage,
the PLP may be dissociating from the apoenzyme, which exposes it to
degradation by phosphatases present in the erythrocytes
(10)
. These data suggest that the EALT activity
coefficient is a more reliable measure than the EAST activity
coefficient when samples must be frozen before analysis.
Another consideration is that the subjects in this study all had adequate vitamin B-6 status. In vitamin B-6deficient subjects, proportionally more of the apoenzyme form would be present. The apoenzyme form may be more susceptible to degradation during storage than the holoenzyme form. Thus, aminotransferase activities may be less stable in frozen erythrocytes from vitamin B-6deficient individuals.
In summary, the present study demonstrates that both EALT and EAST enzymes are prone to loss of basal activity when frozen at -20°C, whereas the EALT-AC is a more stable and reliable measure of vitamin B-6 status than EAST-AC. Packed erythrocyte preparations may provide greater EALT and EAST enzyme stability than frozen diluted hemolysate preparations. If EALT activity cannot be measured the same day blood is drawn, samples may be frozen at -20°C for 28 d or at -80°C for no > 84 d; EAST activity should be measured on fresh erythrocytes.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported in part by U.S. Department of Agriculture NRICGP grant #97352004238 and the Agricultural Research Station, College of Agriculture and Home Economics, Washington State University, Pullman, WA. ![]()
4 Abbreviations used: AC, activity coefficient; EALT, erythrocyte alanine aminotransferase; EAST, erythrocyte aspartate aminotransferase; EGOT, erythrocyte glutamic oxaloacetic transaminase; EGPT, erythrocyte glutamic pyruvic transaminase; Hb, hemoglobin; PLP, pyridoxal 5'-phosphate. ![]()
Manuscript received September 25, 2000. Revision accepted February 8, 2001.
| REFERENCES |
|---|
|
|
|---|
1.
Hansen C. M., Leklem J. E., Miller L.T. Changes in vitamin B-6 status indicators of women fed a constant protein diet with varying levels of vitamin B-6. Am. J. Clin. Nutr. 1997;66:1379-1387
2. Huang Y. C., Chen W., Evans M. A., Mitchell M. E., Shultz T. D. Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of vitamin B-6. Am. J. Clin. Nutr. 1998;67:208-220[Abstract]
3. Leklem J. E. Vitamin B-6. Shils M. E. Olson J. A. Shike M. Ross A. C. eds. Modern Nutrition in Health and Disease 1999:413-421 Williams and Wilkins Baltimore, MD.
4. Sauberlich H. E. Vitamin B-6 (pyridoxine). Sauberlich H. E. eds. Laboratory Tests for the Assessment of Nutritional Status 1999:71-102 CRC Press New York, NY.
5.
Brown R. R., Rose D. P., Leklem J. E., Linkswiler H., Anand R. Urinary 4-pyridoxic acid, plasma pyridoxal phosphate, and erythrocyte aminotransferase levels in oral contraceptive users receiving controlled intakes of vitamin B-6. Am. J. Clin. Nutr. 1975;28:10-19
6. Rose D. P., Strong R., Folkard J., Adams P. W. Erythrocyte aminotransferase activities in women using oral contraceptives and the effect of vitamin B-6 supplementation. Am. J. Clin. Nutr. 1973;26:48-52
7. Woodring M. J., Storvick C. A. Effect of pyridoxine supplementation on glutamic-pyruvic transaminase and in vitro stimulation in erythrocytes of normal women. Am. J. Clin. Nutr. 1970;23:1385-1395[Medline]
8. Merrill A. H., Henderson J. M. Diseases associated with defects in vitamin B-6 metabolism or utilization. Annu. Rev. Nutr. 1987;7:137-156[Medline]
9. Leklem J. E. Vitamin B-6: a status report. J. Nutr. 1990;120:1503-1507
10. Anderson B. B., Fulford-Jones C. E., Child J. A., Beard M.E.J., Bateman C.J.T. Conversion of vitamin B6 compounds to active forms in the red blood cell. J. Clin. Invest. 1971;50:1901-1909
11. Skala J. H., Waring P. P., Lyons M. F., Rusnak M. G., Alletto J. S. Methodology for determination of blood aminotransferases. Leklem J. E. Reynolds R. D. eds. Methods in Vitamin B-6 Nutrition 1981:171-202 Plenum Press New York, NY.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||